Curis
CRIS
#10201
Rank
NZ$30.21 M
Marketcap
NZ$2.34
Share price
0.00%
Change (1 day)
-65.20%
Change (1 year)

Curis (CRIS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$73.27 Million

According to Curis's latest financial reports the company's total liabilities are NZ$73.27 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Curis - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$83.8 M-8.01%
2023-12-31NZ$91.1 M-7.15%
2022-12-31NZ$98.11 M-6.39%
2021-12-31NZ$0.10 B2.63%
2020-12-31NZ$0.10 B-0.35%
2019-12-31NZ$0.10 B64.21%
2018-12-31NZ$62.4 M-11.01%
2017-12-31NZ$70.12 M70.53%
2016-12-31NZ$41.12 M-7.58%
2015-12-31NZ$44.49 M6.2%
2014-12-31NZ$41.9 M-2.78%
2013-12-31NZ$43.09 M-0.13%
2012-12-31NZ$43.15 M305.59%
2011-12-31NZ$10.64 M59.97%
2010-12-31NZ$6.65 M58.55%
2009-12-31NZ$4.19 M-11.71%
2008-12-31NZ$4.75 M-47.8%
2007-12-31NZ$9.1 M-60.83%
2006-12-31NZ$23.23 M-30.69%
2005-12-31NZ$33.52 M25.77%
2004-12-31NZ$26.65 M2.7%
2003-12-31NZ$25.95 M-69.06%
2002-12-31NZ$83.88 M-20.36%
2001-12-31NZ$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Exelixis
EXEL
NZ$1.14 B 1,465.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.52 B 1,975.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ$0.13 B 91.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$86.68 M 18.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$200.16 B 273,062.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$135.51 B 184,840.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ$23.04 M-68.55%๐Ÿ‡บ๐Ÿ‡ธ USA